Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Muddaser Shah, Faizullah Khan, Saeed Ullah, Ajmal Khan, Jamal Nasser Alsabahi, Rimsha Zainab, Mehnaz Bilal, Saleena Khan, Naseem Rafiq, Najeeb Ur Rehman & Ahmed Al-Harrasi. (2023) Chemical composition and biomedical effects of essential oil from Commiphora foliacea Sprague stem. Journal of Essential Oil Bearing Plants 26:5, pages 1319-1337.
Read now
Read now
Prasad Sanjay Dhiwar, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, Ekta Singh, Abhishek Ghara, Lalmohan Maji, Sindhuja Sengupta & Ganesh Andhale. (2023) An assessment of EGFR and HER2 inhibitors with structure activity relationship of fused pyrimidine derivatives for breast cancer: a brief review. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-18.
Read now
Read now
Tarfah Al-Warhi, Ahmed M El Kerdawy, Mohamed A Said, Amgad Albohy, Zainab M Elsayed, Nada Aljaeed, Eslam B Elkaeed, Wagdy M Eldehna, Hatem A Abdel-Aziz & Miral A Abdelmoaz. (2022) Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights. Drug Design, Development and Therapy 16, pages 1457-1471.
Read now
Read now
Amr Sonousi, Rasha A. Hassan, Eman O. Osman, Amr M. Abdou & Soha H. Emam. (2022) Design and synthesis of novel quinazolinone-based derivatives as EGFR inhibitors with antitumor activity. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 2644-2659.
Read now
Read now
Articles from other publishers (53)
Nitin Srivastava & Anil Kumar Saxena. (2023) Caspase-3 Activators as Anticancer Agents. Current Protein & Peptide Science 24:10, pages 783-804.
Crossref
Crossref
Shazia Hussain, Shabeeb Hussain, Muhammad Naveed Zafar, Irfan Hussain, Faizullah Khan, Ehsan Ullah Mughal & Muhammad Nawaz Tahir. (2023) Preliminary Anticancer Evaluation of New Pd(II) Complexes Bearing NNO Donor Ligands. Saudi Pharmaceutical Journal, pages 101915.
Crossref
Crossref
Nilesh Raghunath Khedkar, Milind Sindkhedkar & Alex Joseph. (2023) Computational Design, Synthesis, and bioevaluation of 2-(Pyrimidin-4-yl)oxazole-4-carboxamide Derivatives: Dual inhibition of EGFRWT and EGFRT790M with ADMET profiling. Bioorganic Chemistry, pages 107027.
Crossref
Crossref
Digambar B. Yevale, Nishith Teraiya, Twinkle D. Lalwani, Rakesh Kumar Ameta & Chetan B. Sangani. (2023) A novel class of pyrazole analogues as aurora kinase A inhibitor: design, synthesis, and anticancer evaluation. Bioorganic Chemistry 141, pages 106901.
Crossref
Crossref
Kakul Husain, Ebraheem Abdu Musad Saleh & Ismail Hassan. (2023) Synthesis, Antibacterial, and Antifungal Evaluation of New Class of Pyrimido[4,5-d]pyrimidine, Pyrazolo[3,4-d]pyrimidine, and Pyrimido[4,5-b]quinoline Derived from α,α-Ketene Dithioacetals as fused Five and Six-membered Heterocycle Derivatives. Russian Journal of Bioorganic Chemistry 49:6, pages 1367-1380.
Crossref
Crossref
Ahmed A. Al-Karmalawy, Mahmoud Rashed, Marwa Sharaky, Hamada S. Abulkhair, Mohamed M. Hammouda, Haytham O. Tawfik & Moataz A. Shaldam. (2023) Novel fused imidazotriazines acting as promising top. II inhibitors and apoptotic inducers with greater selectivity against head and neck tumors: Design, synthesis, and biological assessments. European Journal of Medicinal Chemistry 259, pages 115661.
Crossref
Crossref
Keshav Taruneshwar Jha, Abhimannu Shome, Chahat & Pooja A Chawla. (2023) Recent advances in nitrogen-containing heterocyclic compounds as receptor tyrosine kinase inhibitors for the treatment of cancer: Biological activity and structural activity relationship. Bioorganic Chemistry 138, pages 106680.
Crossref
Crossref
Waleed A. Badawi, Mohamed Samir, Hazem M. Fathy, Tarek M. Okda, Mohamed H. Noureldin, Gamal M.K. Atwa & Omaima M. AboulWafa. (2023) Design, synthesis and molecular docking study of new pyrimidine-based hydrazones with selective anti-proliferative activity against MCF-7 and MDA-MB-231 human breast cancer cell lines. Bioorganic Chemistry 138, pages 106610.
Crossref
Crossref
Menna Tallah M. Sayed, Peter A. Halim, Afaf K. El‐Ansary & Rasha A. Hassan. (2023)
Design, synthesis, anticancer evaluation, and in silico studies of some thieno[2,3‐
d
]pyrimidine derivatives as EGFR inhibitors
. Drug Development Research 84:6, pages 1299-1319.
Crossref
Crossref
Satya Kumar Avula, Najeeb Ur Rehman, Faizullah Khan, Obaid Ullah, Sobia Ahsan Halim, Ajmal Khan, Muhammad U. Anwar, Shaikh Mizanoor Rahman, René Csuk & Ahmed Al-Harrasi. (2023) Triazole‐tethered boswellic acid derivatives against breast cancer: Synthesis, in vitro, and in‐silico studies. Journal of Molecular Structure 1282, pages 135181.
Crossref
Crossref
Omaima M. AboulWafa, Hoda M.G. Daabees & Ahmed H. El-Said. (2023) Benzoxazole-appended piperidine derivatives as novel anticancer candidates against breast cancer. Bioorganic Chemistry 134, pages 106437.
Crossref
Crossref
Eman O. Osman, Soha H. Emam, Amr Sonousi, Mai M. Kandil, Amr M. Abdou & Rasha A. Hassan. (2023) Design, synthesis, anticancer, and antibacterial evaluation of some quinazolinone‐based derivatives as DHFR inhibitors. Drug Development Research.
Crossref
Crossref
Safaa E. Seif, Zeinab Mahmoud, Wagnat W. Wardakhan, Amr M. Abdou & Rasha A. Hassan. (2023)
Design and synthesis of novel hexahydrobenzo[4,5]thieno[2,3‐
d
]pyrimidine derivatives as potential anticancer agents with antiangiogenic activity via VEGFR‐2 inhibition, and down‐regulation of PI3K/AKT/mTOR signaling pathway
. Drug Development Research.
Crossref
Crossref
Muddaser Shah, Faizullah Khan, Saeed Ullah, Tapan Kumar Mohanta, Ajmal Khan, Rimsha Zainab, Naseem Rafiq, Hussan Ara, Tanveer Alam, Najeeb Ur Rehman & Ahmed Al-Harrasi. (2023) GC-MS Profiling and Biomedical Applications of Essential Oil of Euphorbia larica Boiss.: A New Report. Antioxidants 12:3, pages 662.
Crossref
Crossref
Israa A. Abdel-Azziz, Noha H. Amin, Mohamed T. El-Saadi & Hamdy M. Abdel-Rahman. (2023) Design, synthesis and mechanistic studies of benzophenones hydrazone derivatives as cathepsin inhibitors. Journal of Molecular Structure 1274, pages 134583.
Crossref
Crossref
Khodayar Gholivand, Azam Barzegari, Mostafa Yousefian, Rahime Eshaghi Malekshah & Mohammad Faraghi. (2023) Experimental and theoretical evaluation of biological properties of a phosphoramide functionalized graphene oxide. Biocatalysis and Agricultural Biotechnology 47, pages 102612.
Crossref
Crossref
Asmaa E. Kassab. (2022)
Pyrazolo[3,4‐
d
]pyrimidine scaffold: A review on synthetic approaches and EGFR and VEGFR inhibitory activities
. Archiv der Pharmazie 356:1.
Crossref
Crossref
Sunil Kumar Patnaik, M.J.N. Chandrasekar, Palathoti Nagarjuna, Deepthi Ramamurthi & Akey Krishna Swaroop. (2022) Targeting of ErbB1, ErbB2, and their Dual Targeting Using Small Molecules
and Natural Peptides: Blocking EGFR Cell Signaling Pathways in
Cancer: A Mini-Review. Mini-Reviews in Medicinal Chemistry 22:22, pages 2831-2846.
Crossref
Crossref
Kunyu Shi, Guan Wang, Junping Pei, Jifa Zhang, Jiaxing Wang, Liang Ouyang, Yuxi Wang & Weimin Li. (2022) Emerging strategies to overcome resistance to third-generation EGFR inhibitors. Journal of Hematology & Oncology 15:1.
Crossref
Crossref
Ahmed S. Ismael, Noha H. Amin, Mohammed T. Elsaadi & Hamdy M. Abdel-Rahman. (2022) Design, synthesis and mechanistic studies of novel imidazo[1,2-a]pyridines as anticancer agents. Bioorganic Chemistry 128, pages 106042.
Crossref
Crossref
Majid Khan, Syed Raza Shah, Faizullah Khan, Sobia Ahsan Halim, Shaikh Mizanoor Rahman, Mohammad Khalid, Ajmal Khan & Ahmed Al-Harrasi. (2022) Efficient Synthesis with Green Chemistry Approach of Novel Pharmacophores of Imidazole-Based Hybrids for Tumor Treatment: Mechanistic Insights from In Situ to In Silico. Cancers 14:20, pages 5079.
Crossref
Crossref
Chinweike Cosmas Eze, Amarachukwu Mercy Ezeokonkwo, Izuchukwu David Ugwu, Uchenna Florence Eze, Ebuka Leonard Onyeyilim, Izuchi Solomon Attah & Ifeoma Vivian Okonkwo. (2022) Azole-Pyrimidine Hybrid Anticancer Agents: A Review of Molecular Structure,
Structure Activity Relationship, and Molecular Docking. Anti-Cancer Agents in Medicinal Chemistry 22:16, pages 2822-2851.
Crossref
Crossref
Chaoyong Liu, De Hao, Minghua Ai, Yan Zhang, Jie Li & Chao Xu. (2022) The long non-coding RNA UPAT promotes gastric cancer cell progression via UHRF1. Genes & Genomics 44:10, pages 1283-1300.
Crossref
Crossref
Muddaser Shah, Saif Khalfan Al-Housni, Faizullah Khan, Saeed Ullah, Jamal Nasser Al-Sabahi, Ajmal Khan, Balqees Essa Mohammed Al-Yahyaei, Houda Al-Ruqaishi, Najeeb Ur Rehman & Ahmed Al-Harrasi. (2022) First Report on Comparative Essential Oil Profile of Stem and Leaves of Blepharispermum hirtum Oliver and Their Antidiabetic and Anticancer Effects. Metabolites 12:10, pages 907.
Crossref
Crossref
Dening Chang, Yanda Li, Yuxuan Chen, Xiaojing Wang, Dejin Zang & Teng Liu. (2022) Polyoxometalate-based nanocomposites for antitumor and antibacterial applications. Nanoscale Advances 4:18, pages 3689-3706.
Crossref
Crossref
Ezaddine Irrou, Younesse Ait Elmachkouri, Ali Oubella, Hassan Ouchtak, Samira Dalbouha, Joel T. Mague, Tuncer Hökelek, Lhoussaine El Ghayati, Nada Kheira Sebbar & Mohamed Labd Taha. (2022)
Crystal structure determination, Hirshfeld surface, crystal void, intermolecular interaction energy analyses, as well as DFT and energy framework calculations of 2-(4-oxo-4,5-dihydro-1
H
-pyrazolo[3,4-
d
]pyrimidin-1-yl)acetic acid
. Acta Crystallographica Section E Crystallographic Communications 78:9, pages 953-960.
Crossref
Crossref
Lalitha Gummidi, Nagaraju Kerru, Adebayo A. Adeniyi, Sanjeev Dhawan & Parvesh Singh. (2022) Comparative experimental and DFT analysis of novel indole tagged [1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one hybrid. Journal of Molecular Structure 1263, pages 133159.
Crossref
Crossref
Omaima Mohamed AboulWafa, Hoda Mohamed Gamal El-Din Daabees & Eman Salah Ezz-ElDien. (2022) Design and Synthesis of Novel Quinazolinone-Based Oxobutanenitrile Derivatives as
Antiproliferative Agents Targeting Human Breast Cancer. Anti-Cancer Agents in Medicinal Chemistry 22:12, pages 2310-2326.
Crossref
Crossref
Tanuja T. Yadav, Gulam Moin Shaikh, Maushmi S. Kumar, Meena Chintamaneni & Mayur YC. (2022) A Review on Fused Pyrimidine Systems as EGFR Inhibitors and Their Structure–Activity Relationship. Frontiers in Chemistry 10.
Crossref
Crossref
Wen Li, Jinyang Zhang, Min Wang, Ru Dong, Xin Zhou, Xin Zheng & Liping Sun. (2022) Pyrimidine-fused Dinitrogenous Penta-heterocycles as a Privileged Scaffold
for Anti-Cancer Drug Discovery. Current Topics in Medicinal Chemistry 22:4, pages 284-304.
Crossref
Crossref
Liping Hu, Mengmeng Fan, Shengmin Shi, Xiaomeng Song, Fei Wang, Huan He & Baohui Qi. (2022) Dual target inhibitors based on EGFR: Promising anticancer agents for the treatment of cancers (2017-). European Journal of Medicinal Chemistry 227, pages 113963.
Crossref
Crossref
Ramachandran Chelliah & Deog-Hwan Oh. 2022. Methods in Actinobacteriology. Methods in Actinobacteriology
427
429
.
Sahar M. Abou-Seri, Amal A.M. Eissa, Mohamed G.M. Behery & Farghaly A. Omar. (2021) Synthesis, in vitro anticancer activity and in silico studies of certain isoxazole-based carboxamides, ureates, and hydrazones as potential inhibitors of VEGFR2. Bioorganic Chemistry 116, pages 105334.
Crossref
Crossref
Yao Guo, Qin Zhao, Yingying Tian, Yuanyuan Liu, Ziyi Yan, Changhu Xue & Jingfeng Wang. (2021) Study on the effects of the different polar group of EPA-enriched phospholipids on the proliferation and apoptosis in 95D cells. Marine Life Science & Technology 3:4, pages 519-528.
Crossref
Crossref
Adileh Ayati, Setareh Moghimi, Mahsa Toolabi & Alireza Foroumadi. (2021) Pyrimidine-based EGFR TK inhibitors in targeted cancer therapy. European Journal of Medicinal Chemistry 221, pages 113523.
Crossref
Crossref
Ahmed M. Farghaly, Omaima M. AboulWafa, Hoda H. Baghdadi, Heba A. Abd El Razik, Samir M.Y. Sedra & Marium M. Shamaa. (2021) New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells. Bioorganic Chemistry 115, pages 105208.
Crossref
Crossref
Barbara Cacciari, Romeo Romagnoli, Arianna Romani, Alessandro Trentini & Stefania Hanau. (2021) Thio-substituted derivatives of 4-amino-pyrazolo[3,4-d]pyrimidine-6-thiol as antiproliferative agents. Future Medicinal Chemistry 13:18, pages 1515-1530.
Crossref
Crossref
Ahmed A. Gaber, Ahmed M. El‐Morsy, Farag F. Sherbiny, Ashraf H. Bayoumi, Kamal M. El‐Gamal, Khaled El‐Adl, Ahmed A. Al‐Karmalawy, Rogy R. Ezz Eldin, Marwa A. Saleh & Hamada S. Abulkhair. (2021)
Pharmacophore‐linked pyrazolo[3,4‐
d
]pyrimidines as EGFR‐TK inhibitors: Synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies
. Archiv der Pharmazie.
Crossref
Crossref
Poonam Yadav, Ramakant Yadav, Shweta Jain & Ankur Vaidya. (2021) Caspase‐3: A primary target for natural and synthetic compounds for cancer therapy. Chemical Biology & Drug Design 98:1, pages 144-165.
Crossref
Crossref
Nahid Abbas, Gurubasavaraja S.P. Matada, Prasad S. Dhiwar, Shilpa Patel & Giles Devasahayam. (2021) Fused and Substituted Pyrimidine Derivatives as Profound Anti-Cancer Agents. Anti-Cancer Agents in Medicinal Chemistry 21:7, pages 861-893.
Crossref
Crossref
Busra O. Aydin, Derya Anil & Yeliz Demir. (2021)
Synthesis of
N
‐alkylated pyrazolo[3,4‐
d
]pyrimidine analogs and evaluation of acetylcholinesterase and carbonic anhydrase inhibition properties
. Archiv der Pharmazie 354:5.
Crossref
Crossref
Xiaozhen Zhan, Wanqing Teng, Kai Sun, Jiexiang He, Jie Yang, Jinhuan Tian, Xun Huang, Lin Zhou & Changren Zhou. (2021) CD47-mediated DTIC-loaded chitosan oligosaccharide-grafted nGO for synergistic chemo-photothermal therapy against malignant melanoma. Materials Science and Engineering: C 123, pages 112014.
Crossref
Crossref
Naglaa M. Ahmed, Mahmoud M. Youns, Moustafa K. Soltan & Ahmed M. Said. (2021) Design, Synthesis, Molecular Modeling and Antitumor Evaluation of Novel Indolyl-Pyrimidine Derivatives with EGFR Inhibitory Activity. Molecules 26:7, pages 1838.
Crossref
Crossref
Noha H. Amin, Mohammed T. Elsaadi, Shimaa S. Zaki & Hamdy M. Abdel-Rahman. (2020) Design, synthesis and molecular modeling studies of 2-styrylquinazoline derivatives as EGFR inhibitors and apoptosis inducers. Bioorganic Chemistry 105, pages 104358.
Crossref
Crossref
Lalitha Gummidi, Nagaraju Kerru, Paul Awolade, Asif Raza, Arun K. Sharma & Parvesh Singh. (2020) Synthesis of indole-tethered [1,3,4]thiadiazolo and [1,3,4]oxadiazolo[3,2-a]pyrimidin-5-one hybrids as anti-pancreatic cancer agents. Bioorganic & Medicinal Chemistry Letters 30:22, pages 127544.
Crossref
Crossref
Daniel J. Baillache & Asier Unciti-Broceta. (2020)
Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4-
d
]pyrimidine scaffold
. RSC Medicinal Chemistry 11:10, pages 1112-1135.
Crossref
Crossref
Zhen-Wang Li, Chun-Yan Zhong, Xiao-Ran Wang, Shi-Nian Li, Chun-Yuan Pan, Xin Wang & Xian-Yu Sun. (2020) Synthesis and Evaluation of the Antitumor Activity of Novel 1-(4-Substituted phenyl)-2-ethyl Imidazole Apoptosis Inducers In Vitro. Molecules 25:18, pages 4293.
Crossref
Crossref
Rui-Li Zhang, Ainiwaer Aimudula, Jiang-Hong Dai & Yong-Xing Bao. (2020)
RASA1 inhibits the progression of renal cell carcinoma by decreasing the expression of miR-223-3p and promoting the expression of
FBXW7
. Bioscience Reports 40:7.
Crossref
Crossref
Asmaa E. Kassab, Yara El‐Dash & Ehab M. Gedawy. (2020) Novel pyrazolopyrimidine urea derivatives: Synthesis, antiproliferative activity, VEGFR‐2 inhibition, and effects on the cell cycle profile. Archiv der Pharmazie 353:4.
Crossref
Crossref
Supreet Gaonkar, Mohammed Azharuddin Savanur, AfraQuasar A. Nadaf, Mahesh S. Najare, Shivaraj Mantur, Manjunatha Garbhagudi, Sikandar I. Mulla & Imtiyaz Ahmed M. Khazi. (2020)
Novel pyrazolo[3,4‐
d
]pyrimidine derivatives inhibit human cancer cell proliferation and induce apoptosis by ROS generation
. Archiv der Pharmazie 353:4, pages 1900296.
Crossref
Crossref
Ramasamy Balagurunathan, Manikkam Radhakrishnan, Thangavel Shanmugasundaram, Venugopal Gopikrishnan & Joseph JerrineRamasamy Balagurunathan, Manikkam Radhakrishnan, Thangavel Shanmugasundaram, Venugopal Gopikrishnan & Joseph Jerrine. 2020. Protocols in Actinobacterial Research. Protocols in Actinobacterial Research
65
112
.
Bijivemula N. Reddy, Radhakrishnam Raju. Ruddarraju, Gangarapu. Kiran, Madhvesh Pathak & Anreddy Rama Narsimha Reddy. (2019)
Novel Pyrazolo[3,4‐
d
]pyrimidine‐Containing Amide Derivatives: Synthesis, Molecular Docking, In Vitro and In Vivo Antidiabetic Activity
. ChemistrySelect 4:34, pages 10072-10078.
Crossref
Crossref
Kanagasabai Somakala, Sana Tariq & Mohd. Amir. (2019) Synthesis, evaluation and docking of novel pyrazolo pyrimidines as potent p38α MAP kinase inhibitors with improved anti-inflammatory, ulcerogenic and TNF-α inhibitory properties. Bioorganic Chemistry 87, pages 550-559.
Crossref
Crossref